Pure Global

RENJI Novel Coronavirus (COVID-19) Nucleic Acid Detection Kit (Real-time RT-PCR Method) - Indonesia BPOM Medical Device Registration

RENJI Novel Coronavirus (COVID-19) Nucleic Acid Detection Kit (Real-time RT-PCR Method) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303321184. The device is manufactured by CHANGSHA RENJI MEDICAL EQUIPMENT CO.,LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. JUOSPUR MULTI PELITA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
RENJI Novel Coronavirus (COVID-19) Nucleic Acid Detection Kit (Real-time RT-PCR Method)
Analysis ID: AKL 20303321184

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. JUOSPUR MULTI PELITA

AR Address

JUOSPUR MULTI PELITA

Registration Date

Jun 06, 2023

Expiry Date

Nov 14, 2026

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from CHANGSHA RENJI MEDICAL EQUIPMENT CO.,LTD.
Products from the same manufacturer (2 products)